R. Kinas

571 total citations
30 papers, 430 citations indexed

About

R. Kinas is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, R. Kinas has authored 30 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 8 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in R. Kinas's work include Organophosphorus compounds synthesis (11 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (8 papers) and Chemical Reactions and Isotopes (8 papers). R. Kinas is often cited by papers focused on Organophosphorus compounds synthesis (11 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (8 papers) and Chemical Reactions and Isotopes (8 papers). R. Kinas collaborates with scholars based in Poland, Germany and Russia. R. Kinas's co-authors include Wojciech J. Stec, Michael Jarman, Janina Baraniak, Krystyna Lesiak, Krzysztof W. Pankiewicz, P. B. Farmer, Peter Burgers, D. H. Hunneman, Wolfram Saenger and And̀rzej Okruszek and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

R. Kinas

29 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kinas Poland 13 162 160 76 67 66 30 430
Peter C. Ruenitz United States 17 254 1.6× 268 1.7× 38 0.5× 118 1.8× 143 2.2× 57 811
Ralf Plate Netherlands 15 250 1.5× 291 1.8× 40 0.5× 42 0.6× 62 0.9× 47 586
Kenneth Crawford United States 13 241 1.5× 313 2.0× 72 0.9× 93 1.4× 107 1.6× 16 615
Milton Heller United States 12 198 1.2× 101 0.6× 55 0.7× 22 0.3× 38 0.6× 38 411
A. Kaiser Switzerland 11 147 0.9× 161 1.0× 17 0.2× 51 0.8× 24 0.4× 17 365
Naresh K. Chadha United States 11 172 1.1× 420 2.6× 32 0.4× 37 0.6× 24 0.4× 14 546
Edward F. Kleinman United States 12 205 1.3× 298 1.9× 26 0.3× 67 1.0× 18 0.3× 19 493
Jerome A. Iacobelli United States 9 145 0.9× 288 1.8× 95 1.3× 43 0.6× 14 0.2× 12 423
J.K.Y. Wong United States 11 272 1.7× 238 1.5× 32 0.4× 61 0.9× 20 0.3× 28 498
B. M. HENNESSY United States 9 143 0.9× 309 1.9× 117 1.5× 46 0.7× 14 0.2× 14 463

Countries citing papers authored by R. Kinas

Since Specialization
Citations

This map shows the geographic impact of R. Kinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kinas more than expected).

Fields of papers citing papers by R. Kinas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kinas. The network helps show where R. Kinas may publish in the future.

Co-authorship network of co-authors of R. Kinas

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kinas. A scholar is included among the top collaborators of R. Kinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kinas. R. Kinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misiura, Konrad, et al.. (2002). Studies on the Side-chain Hydroxylation of Ifosfamide and Its Bromo Analogue. Bioorganic & Medicinal Chemistry Letters. 12(3). 427–431. 2 indexed citations
2.
Misiura, Konrad, et al.. (2001). (S)-(−)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice. Anti-Cancer Drugs. 12(5). 453–458. 3 indexed citations
3.
Sochacki, Marek, et al.. (1998). Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide.. PubMed. 49(6). 463–9. 1 indexed citations
4.
Petrovskii, P. V., et al.. (1995). Enantiomeric 2-anilino-2-oxo-1,3,2-oxazaphosphorinanes: Synthesis and NMR-investigation of their non-racemic mixtures. Tetrahedron Asymmetry. 6(7). 1813–1824. 26 indexed citations
5.
Kinas, R., et al.. (1993). Sister chromatid exchanges induced in vitro in human lymphocytes by N-substituted phosphorodiamidic acids.. Acta Biochimica Polonica. 40(1). 77–79. 1 indexed citations
6.
Studzian, Kazimierz, et al.. (1992). Effects of alkylating metabolites of ifosfamide and its bromo analogues on DNA of HeLa cells. Biochemical Pharmacology. 43(5). 937–943. 7 indexed citations
7.
Misiura, Konrad, et al.. (1988). Synthesis and antitumor activity of analogs of ifosfamide modified in the N-(2-chloroethyl) group. Journal of Medicinal Chemistry. 31(1). 226–230. 15 indexed citations
8.
Mastryukova, T. A., et al.. (1987). Synthesis of Some Substituted 1,3,2-Oxazaphosphorinanes. Phosphorous and Sulfur and the Related Elements. 30(3-4). 793–793. 1 indexed citations
9.
Radzikowski, C, et al.. (1986). Antitumor Activity of Optical Isomers of Cyclophosphamide, Ifosfamide and Trofosfamide as Compared to Clinically Used Racemate+. Immunopharmacology and Immunotoxicology. 8(4). 455–480. 12 indexed citations
10.
Gombler, W., R. Kinas, & Wojciech J. Stec. (1983). 31P−15N Coupling Constants and 15N/14N Isotope Effects on 31P NMR Chemical Shifts of 2-Phenylamino-2-oxo(-thioxo, -selenoxo)- 4-methyl-1,3,2-dioxaphosphorinanes and Related Compounds. Zeitschrift für Naturforschung B. 38(7). 815–818. 15 indexed citations
11.
Baraniak, Janina, R. Kinas, Krystyna Lesiak, & Wojciech J. Stec. (1979). Stereospecific synthesis of adenosine 3′,5′-(SP)- and -(RP)-cyclic phosphorothioates (cAMPS). Journal of the Chemical Society Chemical Communications. 0(21). 940–941. 74 indexed citations
12.
Cox, Peter J., P. B. Farmer, Michael Jarman, R. Kinas, & Wojciech J. Stec. (1978). STEREOSELECTIVITY IN THE METABOLISM OF THE ENANTIOMERS OF CYCLOPHOSPHAMIDE IN MICE, RATS, AND RABBITS. Drug Metabolism and Disposition. 6(6). 617–622. 22 indexed citations
13.
14.
Adamiak, Dorota A., R. Kinas, Wolfram Saenger, & Wojciech J. Stec. (1977). Absolute Konfiguration des Cancerostaticums S(−)‐Cyclophosphamid. Angewandte Chemie. 89(5). 336–336. 7 indexed citations
15.
Cox, Pablo, P. B. Farmer, A. B. Foster, et al.. (1977). Application of deuterium labelling mass spectrometry in a study of the metabolism of the enantiomers of cyclophosphamide. Journal of Mass Spectrometry. 4(6). 371–375. 13 indexed citations
16.
17.
Adamiak, Ryszard W., R. Kinas, Wolfram Saenger, & Wojciech J. Stec. (1977). ChemInform Abstract: ABSOLUTE CONFIGURATION OF THE CANCEROSTATIC S(‐)‐CYCLOPHOSPHAMIDE. Chemischer Informationsdienst. 8(33).
18.
Adamiak, Ryszard W., Wolfram Saenger, R. Kinas, & Wojciech J. Stec. (1977). X-Ray-Diffraction Study and Determination of Absolute Configuration of the Anticancer Drug S(–) Cyclophosphamide (Endoxan, Cytoxan, NSC-26271). Zeitschrift für Naturforschung C. 32(9-10). 672–677. 7 indexed citations
19.
Stec, Wojciech J., R. Kinas, & And̀rzej Okruszek. (1976). Notizen: Configurational Assignments to 2-X-2-Y-4-methyl-1,3,2-dioxaphosphorinans. Zeitschrift für Naturforschung B. 31(3). 393–395. 7 indexed citations
20.
Bartczak, T.J., A. Christensen, R. Kinas, & Wojciech J. Stec. (1975). Synthesis and cis-trans-geometry assignment in diastereoisomeric 2-t-butylamino-4-methyl-1,3,2-dioxaphosphorinans and their 2-seleno derivatives. Tetrahedron Letters. 16(37). 3243–3246. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C. Ruenitz Breakdown of academic impact, for papers by Ralf Plate Breakdown of academic impact, for papers by Kenneth Crawford Breakdown of academic impact, for papers by Milton Heller Breakdown of academic impact, for papers by A. Kaiser Breakdown of academic impact, for papers by Naresh K. Chadha Breakdown of academic impact, for papers by Edward F. Kleinman Breakdown of academic impact, for papers by Jerome A. Iacobelli Breakdown of academic impact, for papers by J.K.Y. Wong Breakdown of academic impact, for papers by B. M. HENNESSY
Rankless by CCL
2026